CI Canadian Convertible Bond ETF Common (TSE:CXF - Get Free Report) traded up 0.4% on Friday . The company traded as high as C$10.25 and last traded at C$10.25. 900 shares traded hands during trading, a decline of 78% from the average session volume of 4,138 shares. The stock had previously closed at C$10.21.
CI Canadian Convertible Bond ETF Common Stock Performance
The business's 50 day simple moving average is C$10.09 and its two-hundred day simple moving average is C$10.09.
CI Canadian Convertible Bond ETF Common Company Profile
(
Get Free Report)
Chimerix, Inc, a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CI Canadian Convertible Bond ETF Common, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CI Canadian Convertible Bond ETF Common wasn't on the list.
While CI Canadian Convertible Bond ETF Common currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
